Welcome to our dedicated page for Ingersoll-Rand SEC filings (Ticker: IR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions. These filings offer detailed information on the company’s operations, governance, and financial performance across its Industrial Technologies and Services and Precision and Science Technologies segments.
Ingersoll Rand regularly files Current Reports on Form 8-K to disclose material events. Recent 8-K filings include reports on quarterly financial results, where the company furnishes earnings press releases that discuss segment orders, revenues, Adjusted EBITDA, and guidance, as well as filings related to board changes. For example, the company has filed 8-Ks describing the appointment of new independent directors and their committee assignments, including roles on the Compensation, Sustainability, and Nominating and Corporate Governance Committees.
Through this filings page, users can also review documents that explain how Ingersoll Rand uses non-GAAP financial measures such as Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, and Free Cash Flow Margin. The company’s disclosures describe how these metrics are calculated, why management and the board use them, and how they relate to liquidity, capital allocation, and performance evaluation.
Stock Titan enhances these regulatory documents with AI-powered summaries that help interpret key points from lengthy filings. As new IR filings are posted to EDGAR, they are updated here, allowing investors to quickly locate quarterly results, material event disclosures, and governance updates. Users interested in topics such as segment performance, capital allocation, director appointments, or the company’s use of non-GAAP metrics can use this page as a central reference for Ingersoll Rand’s official SEC reporting history.
A shareholder of IR has filed a notice under Rule 144 to sell up to 1,477 shares of common stock through Fidelity Brokerage Services LLC. The shares have an indicated aggregate market value of 119,085.93, and the planned sale is listed for around 12/01/2025 on the NYSE. The shares to be sold were acquired from the issuer through restricted stock vesting on 02/22/2024 and 02/23/2024, in amounts of 459 and 1,018 shares as compensation. The filing also notes that 395,110,395 shares of this class of stock were outstanding, giving investors a sense of the overall share base relative to this planned sale.
Capital World Investors filed an amended Schedule 13G reporting a passive stake in Ingersoll Rand (IR). The firm is deemed to beneficially own 32,118,760 shares, representing 8.1% of the 397,452,515 shares believed outstanding. The filing lists sole voting power over 31,968,872 shares and sole dispositive power over 32,118,760 shares, with no shared voting or dispositive power.
The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Ingersoll Rand (IR): Schedule 13G/A filed by Capital International Investors. The investor reports beneficial ownership of 51,326,399 shares of Ingersoll Rand common stock, representing 12.9% of the class. The filing cites 397,452,515 shares believed outstanding.
Capital International Investors reports sole voting power over 51,102,969 shares and sole dispositive power over 51,326,399 shares, with no shared voting or dispositive power. The certification states the securities “were acquired and are held in the ordinary course of business” and not for the purpose or effect of changing or influencing control. The date of event triggering this amendment is 09/30/2025.
Ingersoll Rand Inc. reported third‑quarter results in its 10‑Q. Q3 2025 revenue was $1,955.0 million (up from $1,861.0 million), with operating income of $375.5 million and diluted EPS of $0.61.
Year‑to‑date performance reflected non‑cash charges: goodwill impairment of $229.7 million, other intangible impairment of $36.1 million, and a loss on equity method investments of $127.1 million, leading to net income of $320.4 million (vs. $614.4 million a year ago). Cash from operations was robust at $856.7 million for the nine months ended September 30, 2025.
The company completed $496.1 million of acquisitions in 2025, including $193.7 million for TMIC/Adicomp. It used $703.3 million for share repurchases over the same period. As of September 30, 2025, cash was $1,176.6 million and long‑term debt was $4,786.7 million. Shares outstanding were 395,110,395 as of October 24, 2025.
Ingersoll Rand Inc. reported its financial results for the quarter ended September 30, 2025 and announced them in a press release dated October 30, 2025. The company furnished this press release as an exhibit so investors can review the full quarterly performance details. The information is provided under disclosure rules for results of operations and financial condition and is not treated as filed for liability purposes.
Form 144 notice for Ingersoll Rand Inc. (IR) reports a proposed sale of 19,055 common shares through Fidelity Brokerage Services with an aggregate market value of $1,533,868.04, scheduled approximately for 08/27/2025 on the NYSE. The filing lists the shares sold as resulting from restricted stock vesting on specific dates between 03/06/2021 and 02/27/2025, totaling the units disclosed in the acquisition table. The filer reports nothing to report for securities sold in the past three months and affirms no undisclosed material adverse information. The notice documents the broker, share count, aggregate value, outstanding shares figure (397,452,515), and the nature of the prior acquisitions (compensation vesting).
Ingersoll Rand Inc. (IR) Senior Vice President and CFO Vikram Kini received 897 restricted stock units on 08/20/2025, which are reported as a grant (code M) that vests in four equal annual installments beginning 08/20/2025. Upon vesting each unit will settle into one share of common stock, cash, or a combination. The filing shows 392 shares were withheld to cover taxes at a reported price of $79.04, leaving 87,687 shares beneficially owned after the transactions. The reporting also shows 2,694 restricted stock units beneficially owned following the transaction. The form is signed by an attorney-in-fact on 08/21/2025.
Michael A. Weatherred, Senior Vice President, PST Segment, Demand Generation and Execution at Ingersoll Rand Inc. (IR), reported transactions on 08/20/2025 affecting his beneficial ownership.
The filing shows 966 restricted stock units (RSUs) recognized (code M) that vest in four equal annual installments beginning August 20, 2025, and on vesting will be settled in shares, cash, or a combination. After the reported activity, Weatherred beneficially owns 59,154.852 shares of common stock. The form also shows 428 shares were withheld to cover taxes related to RSU vesting at a price of $79.04, leaving 58,726.852 shares reported as beneficially owned for that class. The filing was signed by an attorney-in-fact on behalf of the reporting person.
Ingersoll Rand Inc. (IR) reporting by Kathleen M. Keene, Senior Vice President and Chief Human Resources Officer. The filing discloses restricted stock units (RSUs) scheduled to begin vesting on 08/20/2025: 483 RSUs were recorded as granted and will vest in four equal annual installments, each settled in shares, cash or a combination. To cover taxes on vesting, 212 shares were withheld at $79.04 per share. After these transactions the reporting person beneficially owned 11,650 shares of common stock and 1,450 RSUs/derivative securities.
Elizabeth Meloy Hepding, Senior Vice President, Corporate Development at Ingersoll Rand Inc. (IR), reported insider transactions on 08/20/2025. She was granted 435 restricted stock units (RSUs) that vest in four equal annual installments beginning 08/20/2025 and will settle in shares, cash, or a combination. To cover taxes on vesting, 191 shares were withheld at an indicated price of $79.04. After these transactions, the filing reports 12,651 shares beneficially owned. The Form 4 was signed by an attorney-in-fact on 08/21/2025.